Abstract
Chitosan is one of the most environmental purification functional natural polysaccharides that can successfully prohibit the reproduction and growth of harmful Gram-negative and Gram-positive bacterial pathogens and also control the toxic pollutants. Nowadays, pathogenic microorganisms have multidrug resistance to antimicrobial drugs; therefore, successful identification and management of contagious disorders has become a major impediment. For combating the multidrug resistances in microorganisms’ the latest innovations in nanotechnology-based medications have released novel prospects. More attention has been paid to the use of silver nanoparticles (AgNPs) as an effective antibacterial agent. Silver nanoparticles have been used to prevent and cure numerous contagions and disorders due to their strong bactericidal effects. Silver nanoparticles have high bactericidal and antimicrobial actions against methicillin-resistant bacterial strains, e.g., Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli, etc. The formation of nanoparticles from chitosan sources has been paid pronounced consideration due to hydrophilic characteristics, biodegradability, and biocompatibility. The first part of the literature highlights a general mechanism of antibacterial activity of chitosan, whereas the second part focus on the antibacterial activity of chitosan conjugated silver nanoparticles against broad-spectrum Gram-negative and Gram-positive microbial pathogens. Chitosan is selected as a protective mediator in the formation of silver nanoparticles because chitosan act as a stabilizing agent as well as the capability to sorb silver ions via chelation and ion exchange mechanisms. Chitosan conjugated silver-nanocomposites were suggested as coatings for food packaging, biomedical-engineering as well as wound-dressing applications.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Chitosan is the second most natural polysaccharide in the universe after cellulose that can be attained through the deacetylation processes of chitin. Outer shells of mollusks, lobsters, microorganisms, and cuticles of insects are the main sources of chitin or chitosan [1]. Table 1 and Fig. 1 show the various sources of chitosan. Decalcified cuticles of the crustacean members possess approximately 55–85% chitin. Secretion of chitin occurs by a single layer of epidermal cells whereas; the endocuticle contains mineral salts, e.g., phosphates of calcium and carbonates [2]. Chitosan possesses prospective uses in medicine, agriculture, paper, textile, pharmaceutical, and food industries. It has been reported as an antioxidant, anti-tumor antifungal antibacterial, anti-inflammatory anti-thrombogenic, immunoadjuvant, and anti-cholesteric agent due to its non-toxicity, biocompatibility, non-allergenicity, and biodegradability properties [3]. Furthermore, it has also numerous uses in the biomedical field, e.g., tissue engineering, gene delivery, drug delivery, and regenerative rehabilitation [4]. Many applications have been attributed at the industrial level due to its solubility in an acidic aqueous medium. Its solubility depends upon the molecular weight, dispersion of the amino and acetyl groups along the chain, and degree of acetylation [5]. Chitosan possesses broad-spectrum anti bactericidal actions against both Gram-Positive and Gram-negative microbes. Additionally, the anti-bacterial activity of chitosan at low pH has been detected higher due to the occurrence of amino groups in the cationic form [6].
Biological and physiochemical characteristics of chitosan
Solubility of Chitosan is found maximum in dilute organic acids, e.g., acetic acid, lactic acid, formic acid, and malic acid insoluble in water due to high viscosity. Chemical features of the chitosan include linear polyamine, reactive –OH groups, the occurrence of reactive amino groups, and a chelating effect with abled transition metal ions. Therefore it could be utilized in numerous high versatility physical forms gels, nanoparticles as filaments and nano-fibers, films, globules, scrubbers, scaffolds, and films [9]. Chitosan contains the following biological features, e.g., DNA binding ability in microbial and mammalian cells, eco-safe, hemostatic, biocompatibility, biodegradability, spermicidal, fungistatic, immunoadjuvant, accelerating effect for bone formation, antitumor, and anti-cholesteremic [10, 11]. Physiochemical features of chitosan (CH) and its determination methods are depicted in Table 2.
Antibacterial effect and mechanism of chitosan
Chitosan in diverse formulas such as solutions, composites, and films has been studied as an antibacterial agent for an extensive range of target entities for example microbes, algae, mushrooms, and fungus in various in vitro and in vivo experiments [14]. Abdel-Razek [15], first proposed the broad-spectrum antibacterial activity of CH and its products. The voyage of investigation, assessment, and technical improvement in the antimicrobial properties of chitosan began two decades ago, on soil–borne and foodborne pathogenic fungi in agriculture as well as food production [16]. Many extrinsic and intrinsic aspects, e.g., molecular weight and pH, relied on the antibacterial actions of chitosan and its by-products [17].
The polycationic chitosan interacts to the anionic charged cell wall of the pathogen then alters the permeability of the plasma membrane, inhibiting the replication of DNA,and disrupts the entire cell which results in apoptosis occurs [18]. Due to chelating activity, it inhibits bacterial growth by binding to trace metal elements and production of toxins [19]. Even, high molecular weight solid and water-soluble chitosan containing larger size nanoparticles obstructive the transference of vital solutes into the cell. It has been stated that two positively charged sites asparagine N-conjugated chitosan oligosaccharide offers resilient communication with the cell wall of bacteria that possess carboxyl-negative charges [20]. The polyatomic structure of chitosan predominantly shows a major function against microbes via electrostatic interaction among the negative constituents of the microbes for example cell surface proteins and lipopolysaccharide [14]. It has been described that the antimicrobial effect is enhanced in the incidence of an abundance of carboxyl group[21]. In acidic conditions, the polycationic structure forms superfluously, because the pKa of chitosan at a higher pH value may change due to protonation [22]. Chandrasekaran et al. [21] described that the antibacterial property of chitosan metal complex as well as chitosan will increase when the concentration of chitosan increases. Various states of the cells situated on the surface of the chitosan microsphere (some were leaking intracellular substances, some were intact)that destroy pathogens via interfacial communication [23].
Aspects affecting the antibacterial property
Concentration of chitosan
In a previous study, it is reported that at different concentrations chitosan can prohibit the growth of bacteria depending upon the acetylation degree. Chitosan with (a 7.5% acetylation degree) was more effective than a solution of chitosan with a 15% acetylation degree [24]. Higher concentrations of protonated CH can hide the receptors on the surface of a cell and stop the outflow of internal constituents whereas, CH binds to the negatively charged cell surface at lower concentrations then disrupts the plasma membrane and cause the decease of the microbes via inducing escape of entire constituents and eventually leads to death of bacteria [25]. It has also been found that chitosan bind to Gram-negative bacteria especially only at lower concentrations [26]. It has also been stated that at the lower concentration (20 ppm) chitosan killed almost all bacterial strains when compared to a higher concentration at 50 ppm [27]. The antibacterial experiment results showed that when cotton fabrics were treated with diverse concentrations of chitosan (0.5–0.75%) a significant antibacterial activity has been found and increasing the concentration of CH (1%) leads to a reduction in antibacterial activity [28].
Molecular weight
Various studies reported that low Mw and high Mw of CH have equivocal results for B. subtilis and E. coli [14]. Xia et al. [14] stated that the molecular weight of chitosan either low or high depends on situations of genetic testing and the bacterial strains. Moreover, HMw (9.3 kDa) and Low molecular weight (4.6 kDa) chitosan and its imitative exhibited enhanced action for mold, fungi, as well as other pathogens. It has also been found that chitosan with high molecular weight (1671, and 1106 kDa) can intermingle with the membrane of the bacteria and stops the transport of nutrients into the plasma membrane of microbes by altering the cell permeability and resulting in cell lysis [29]. However, CH with a low molecular weight (746 kDa) can interact with the nuclei of the microbes and prohibit the synthesis of mRNA [30]. In previous studies, it has also been specified that LMW chitosan revealed stronger bactericidal effects on Gram-negative bacteria, e.g., E. coli and Pseudomonas fluorescens, whereas, chitosan with high HMW (1671 kDa) is more effective against Gram-positive bacteria such as Vibrio parahaemolyticus and Salmonella typhimurium [31].
pH
The antibacterial action of CH depends upon the pH of chitosan [25]. Alarfaj [32] reported that chitosan showed the tougher prohibitory effect at lower pH, due to solubility of chitosan in an acid whereas, the antibacterial activity becomes weak when the pH increases. Some researchers reported that under neutral conditions or at pH 7.0 chitosan and its derivatives finally failed to show their antimicrobial activities because it was tough for chitosan to dissolve in water at pH 7.0 and the amino groups of chitosan were no longer significantly charged at neutral pH [33]. Chitosan is polyatomic due to the high density of amino groups present on the polymer and at pH 6.0 it intermingles freely with negatively charged constituents, e.g., anionic polysaccharides, proteins, fatty acids, phospholipids, and bile acids [34]. However, Yu et al. [23] stated that the chitosan microsphere exhibited antibacterial outcomes. Hosseinnejad and Jafari [22] found that N-alkylated chitosan derivatives indicated the maximum antibacterial activity for E. coli when pH enhanced from 5.0 to 6.0 pH. In another study antibacterial activity of chitosan was investigated at pH 7.4 and 6.2 against Staphylococcus aureus, and at pH 6.2 chitosan more inhibited the growth of bacteria than pH 7.4 [35]
Temperature and time
Specific characteristics of chitosan and its derivatives such as viscosity/molecular weight might be altered during storage [36]. Therefore, for commercial applications, the stability of prepared chitosan solution should be monitored before storage or further use. After four months of storage, stability of chitosan and antimicrobial action against Gram-negative (S. enteritidis and E. coli) and Gram-positive (S. aureus and L. monocytogenes) bacterial strains were inspected at 5 °C and 28 °C [37]. After investigation, it was found that after four months of storage chitosan solutions exhibited less antiseptic action than before storage. In another study, it was also found that Chitosan solutions showed more antibacterial activity at 4 °C as compared to 25 °C. The antibacterial activity of chitosan solutions at different temperatures depends upon the bacterial strains [38]. It was found that E. coli showed higher antibacterial activity as temperature increased from 4 to 37 °C. Xia et al. [14] reported that low temperature can decrease the electronegativity for derivatives of CH by changing the cell surface structure.
Chitosan nanoparticles
Nowadays, (NPs) are used as drug-delivery mediators or nanocarriers to develop safer and more effective treatments for diagnosing, monitoring, and preventing syndromes [39]. Alqahtani [40], found that CNPs exhibited greater antimicrobial action against both Gram-positive and Gram-negative bacteria, and an extensive variety of fungus strains as compared to chitosan. Several approaches have been found for the preparation of chitosan NPs, e.g., microemulsion, ionic gelation, spray drying, reverse micellar method, and emulsion droplet coalescence [21, 41]. Among several approaches, ionic gelation was observed to be the better one. According to the ionic gelation scheme, chitosan (w/v) was liquefied in acetic acid (v/v) and the solution was retained under magnetic stirring at room temperature for 24 h. Then 1 mL 0.1% w/v TPPsolution was added dropwise to 5 mL of CH solution at 800 rpm for 1 h under continuous magnetic stirring. Then the nanoparticles were formed and the solution containing nanoparticles was spinned at 10,000 rpm for 15 min. Then NPs were liquefied in double distilled water and then centrifuged for purification [42]. For further characterization and experiments, the CNPs were kept at room temperature. The synergistic effect of chitosan and metals (gold-, silver- or copper) was explored to prepare a novel nanocomposite against human bacterial strains [43].
Chitosan conjugated silver nanoparticles
The production of NPs from chitosan sources has been given prodigious devotion due to their biocompatibility, hydrophilicity, and biodegradable possessions [44]. It intermingles with negatively charged polymers and molecules due to its positive nature. In the formation of metal NPs, CH has been selected as a protecting agent due to the interface of active α-amine groups in CH with metal nanoparticles [45]. Toward some human cells, chitosan displays an antibacterial action for disease resistance due to the occurrence of both active OH functional and amino groups [46]. Suresh et al. [47] described that recently chitosan has been used as both the stabilizing and reducing agents for the production of Ag NPs. Silver nanoparticles (Ag NPs) possess unique physicochemical properties in the field of biomedicine such as antiviral, antibacterial, anti-inflammatory antiplatelet activities, antifungal, and anti-angiogenesis [47, 48]. In various areas of nanotechnology, the syntheses of metal nanoparticles through the improvement of proficient and greener routes have become a major concern. Among several metal nanoparticles, silver nanoparticles are extensively useful in numerous organic and medicinal areas due to their potential as antimicrobial agents, e.g., wound healing, biosensors, curing the burns, and treating the numerous forms of cancers [49, 50].
Chitosan and PVA are well-recognized polymers with tremendous immersion capacities for various metal ions due to the occurrence of (–NH2) and (–OH) groups in their configuration [51]. It has been documented that CH itself possesses antimicrobial action due to its cationic characteristics that cause a membrane-disrupting effect. However, chitosan–silver nanoparticles (CS/AgNP) signifies a bio-nanostructured hybrid material due to their biodegradability and biocompatibility [52].
Antibacterial mechanism of chitosan conjugated silver nanoparticles
Interaction between chitosan and metal nanoparticles takes place due to the positive amino groups chitosan and negatively charged molecules in bacteria [53]. Chitosan has been selected as a therapeutic mediator in the production of metal NPs. Chitosan shows several noteworthy organic functions such as antimicrobial action for diseaseresistant toward several human cell categories due to the incidence of both active NH and OH groups [45]. For many years silver products have been utilized to inhibit and medicate numerous inflammation and disorders due to their resilient prohibitory and bacteriostatic actions. Silver nanoparticles have high bactericidal and antimicrobial actions against methicillin-resistant bacterial strains such as S. aureus, E. coli, and P. aeruginosa [54]. Apart from stabilization, chitosan also prevents the agglomeration of AgNPs below a critical concentration [55]. Furthermore, the antimicrobial action upsurges with the increased concentration of AgNPs and silver molecules. The greater effective surface area of silver nanoparticles increases the antimicrobial action because chitosan prevents aggregation of AgNPs. The surface area of both silver ions and nanoparticles decreases in the presence of agglomerates and thus the efficiency of antibacterial is greatly diminished [56]. Shah et al. [52] reported that chitosan can sorb silver ions via chelation and ion exchange mechanisms. Chitosan and silver ions interact with each other through a reduction process as a result of electrospinning among single carboxyl and single amino groups of CH with the molecules of silver. A dual mechanism of action of chitosan-based silver nanoparticles is the effect of cationic chitosan and the bactericidal effect of AgNps [52].
The distraction of plasma membrane and destabilization of entire structures
The mechanism of the antimicrobial act of positively charged chitosan-based silver nanoparticles is interacting with the anionic charged cell membrane of bacteria leading to accretion of NPs on the bacterial cell surface. These NPs cause disruption in the permeability of the plasma membrane, altered configuration, transportation action, and destabilization of the cell envelope as shown in Fig. 2 [57]. These nanoparticles release the silver ions from particles and can enter the cell via intermingling with phosphorus- and sulfur-containing compounds, e.g., protein and DNA [58].
Images of Transmission electron microscopy have shown that the antimicrobial activity of the AgNPs can enhance by the usage of anionic detergents such as sodium dodecyl sulfate and Phosphorus-containing heterocyclic surfactants, and non-heterocyclic ammonium and phosphonium surfactants s that are potent stabilizers of AgNPs with significant cytotoxic activity. Silver nanoparticles with phosphonium surfactants were found to be more stable and exhibited substantial antibacterial effects against Gram-negative and Gram-positive pathogens [59, 60]. The outer membrane of the Gram-negative bacteria consists of “porins (water-filled channels) that are responsible for the acceptance of AgNPs into the microbial cells. These NPs also disrupt DNA replication, various enzymes such as DNA-dependent RNA polymerase and DNA gyrase, division, and respiration by binding to mesosomes, thus damage the entire cell [61]. Thiruvengadam Bansod, [62] also stated that the interaction of AgNPs with ribosomes leads to the prohibition of protein synthesis due to the deactivation of SH functional group of the amino acids existing in the cell surface. Ag ( +) ions and AgNPs block active binding sites by interacting with disulfide bonds and modifying the 3D structure of proteins which leads to complete functional imperfections in the bacterial strains [63]. It has also been reported that AgNPs inhibit the metabolism of sugar through the deactivation of the phosphoglucose isomerase [64]. Silver ions can affect the transportation and the discharge of potassium (K +) ions, and escape of cellular constituents, e.g., proteins, reducing sugars and ions from the microbial cells, can also alter [65]. It has been found that Ag ( +) ions disrupt the double-helical structure of microorganisms by breaking the H-bonds found within nucleotides of the antiparallel strands of DNA [66]. Yun’an et al. [67] stated that AgNPs also inhibited the cell division and reproduction of S. aureus in its initial stages.
Formation of ROS
Accumulations of NPs on the plasma membrane of the bacteria produce oxidative stress which results in the release of ROS. These ROS can decline the production of ATP as well as respiration [68]. A higher concentration of Ag ( +) ions causes cellular oxidative stress in microbes due to the generation of free radicals, e.g., hydroxyl radical (OH•), H2O2, singlet oxygen, superoxide anion, as well as hypochlorous acid [69]. During mitochondrial oxidative phosphorylation ROS are also generated intracellularly. Productions of free radicals in excessive amounts cause necrosis in the mitochondrial membrane. It has also been reported that higher production of ROS causes hyper oxidation of DNA proteins and lipids. Silver nanoparticles disrupt and inactivate the catalytic activity of various enzymes due to the production of carbonyls which are protein-bound in the environment through catalyzing the chemical reaction of the amino groups which result in the destruction of polymers occurs [70].
Genotoxicity and inhibition of signal transduction
For bacterial growth and cellular action, the sequence of dephosphorylation and phosphorylation cascade mechanism of signal impart plays a vital role [64]. Therefore, bacterial growth can be repressed by the reticence of phosphorylation of amino acids that will obstruct their catalytic action [71]. Silver NPs interrelate with the DNA/RNA due to their electrical possessions and inhibit the signal transduction by harmful effect on the reproductive procedure of chromosomal and plasmid DNA [72]. A higher antimicrobial of CH-based AgNPs was found against Gram-negative (E. coli) and Gram-positive microbial strains (S. aureus, and B. subtilis) when matched to ionic silver and chitosan itself for S. aureus and E. coli [65].
Effects of physicochemical properties on antibacterial action of AgNPs
In biomedical applications production of metallic derivative nanoparticles relies upon various thermal, chemical, physical, electrical, and photosensitive characteristics [59]. Omran et al. [73] stated that microbial possessions of the silver nanoparticles are intensely affected by their concentration, size, shape, and colloidal state as shown in Fig. 3. It has also been found that the stability and biocompatibility of AgNPs can enhance by reducing their size [74]. Interaction between AgNPs and microorganisms (viruses, bacteria, and fungus) takes place according to shape. Therefore, it is essential to develop applicable shaped and sized NPs with desired superficial characteristics [75]. Treatment with different shaped Ag NPs showed modifications in the plasma membrane of the (E. coli) via energy-filtering TEM images [76]. Antibacterial action of truncated triangular shaped AgNPs has been found better with respect to rod shaped / sphere-shaped. The size of AgNPs is another important physicochemical characteristic that is accountable for the conformation of nanoparticles. The size of silver nanoparticles should not be larger than 50 nm [77]. Liao et al. [78] stated that AgNPs with smaller sizes (< 30 nm) showed more antibacterial action against K. pneumoniae and S. aureus. Both bactericidal as well as bacteriostatic effects against S. aureus have also been found at 5–10 nm dimensions of AgNPs as shown in Table 3 [79]. Small-sized AgNPs attached with the plasma membranes, increased membrane permeability, and modifications in lipid bilayer lead to impairment and apoptosis. Crystallographic surface structures and surface area to volume ratio are significant aspects that describe the antimicrobial action of AgNPs [80].
Due to the multidrug resistance of the pathogenic microbes to the antibacterial medications, successful treatment and diagnosis of pathogenic infections of fungal and bacterial origin have become a major concern [85]. Table 4 comprises a list of antibiotics to which the most communal drug-resistant, pathogenic strains of microbes have developed resistance. Nowadays, to overcome MDR, more consideration has been paid to the development of novel, non-traditional antibacterial agents [86]. In clinical and therapeutic applications the benefit of using silver nanoparticles is comparatively less responsive than silver ions [74]. It has been found that both, non-multidrug resistant, as well as multidrug-resistant bacterial strains, showed more antimicrobial activity against AgNPs [87]. Severe clinical and medical problems, e.g., disorders in the urinary tract, diarrhea, neonatal meningitis, and pneumonia, etc., are associated with Gram-positive pathogens including Enterococcus, Nocardia, Clostridium, Actinomyces, Mycobacterium Staphylococcus, Bacillus, Corynebacterium, Listeria, Streptomyces, and Streptococcus [88]. Among them are antibiotic-resistant microbes; E. faecium is vancomycin-resistant, methicillin- and vancomycin-resistant S. aureus, penicillin-resistant Streptococcus pneumonia, and multidrug-resistant Listeria Corynebacterium and macrolides resistant Streptococcus pyogenes. The two most dominant and pathogenic Gram-negative bacteria enterotoxin Escherichia coli (ETEC) and Vibrio cholerae have high morbidity and mortality rate through severe secretory diarrhea [89]. Among Gram-negative bacterial strains K. pneumoniae, Acinetobacter baumanii, and Pseudomonas aeruginosa some are opportunistic microorganisms that infect mainly immune-compromised patients and are intrinsically resistant to multiple drugs [90]. Niño-Martínez et al. [91] stated that the antiseptic action of silver nanoparticles has been found in contradiction to drug-resistant pathogenic strains of bacteria, e.g., E. faecalis, Bacillus subtilis, E. coli, P. aeruginosa, S. aureus, and K. pneumonia. Antimicrobial effect of silver nanoparticles has also been found against S. typhi, S. pyogenes, methicillin-resistant Staphylococcus epidermidis, and K. pneumonia and methicillin-resistant S. aureus (MRSA). Antibacterial effect of AgNPs only or amalgamation with antibiotics against drug-resistant bacterial strains has also been found [92].
Conclusion
The current study showed that nowadays pathogenic microorganisms have multidrug resistance to antimicrobial drugs therefore, successful diagnosis and management of infectious disorders has become a foremost barrier. Significant antibacterial action of CH has been found against a broad spectrum of microorganisms. Chitosan-silver nanoparticles (CS/AgNPs) signify bio-nanostructured crossbreed constituents due to their biocompatibility, and biodegradability with improved antimicrobial characteristics. Bactericidal possessions of the AgNPs can be intensely affected through their size, concentration, shape, and colloidal state. Silver nanoparticles of smaller size (< 30 nm) showed more antibacterial action against Gram-positive and Gram-negative bacterial pathogens. Chitosan-conjugated silver-nanocomposites were suggested as coatings for food packaging, biomedical-engineering as well as wound-dressing applications.
Abbreviations
- CH:
-
Chitosan
- NPs:
-
Nanoparticles
- Ag NPs:
-
Silver nanoparticles
- ROS:
-
Reactive oxygen species
- OH:
-
Hydroxyl group
- TEM:
-
Transmission electron microscopic
- MDR:
-
Multiple drug resistant
References
Kalantari K, Afifi AM, Jahangirian H, Webster TJ (2019) Biomedical applications of chitosan electrospun nanofibers as a green polymer-review. Carbohydr poly 207:588–600
Zhao X, Zhang J, Zhu KY (2019) Chito-protein matrices in arthropod exoskeletons and peritrophic matrices. Springer, Extracellular Sugar-Based Biopolymers Matrices, pp 3–56
Ojeda-Hernández DD, Canales-Aguirre AA, Matias-Guiu J, Gomez-Pinedo U, Mateos-Díaz JC (2020) Potential of chitosan and its derivatives for biomedical applications in the central nervous system. Front Bioeng Biotechnol 8:389
Ahsan SM, Thomas M, Reddy KK, Sooraparaju SG, Asthana A, Bhatnagar I (2018) Chitosan as biomaterial in drug delivery and tissue engineering. Int J Biol Macromol 10:97–109
Yadav MK, Pokhrel S, Yadav PN (2020) Novel chitosan derivatives of 2-imidazolecarboxaldehyde and 2-thiophenecarboxaldehyde and their antibacterial activity. J Macromol Sci Part A 57(10):703–710
Madni A, Kousar R, Naeem N, Wahid F (2021) Recent advancements in applications of chitosan-based biomaterials for skin tissue engineering. J Bioresour Bioprod 6(1):11–25
Yang L, Wang Q, Peng L, Yue H, Zhang Z (2015) Vascularization of repaired limb bone defects using chitosan-β-tricalcium phosphate composite as a tissue engineering bone scaffold. Mol Med Rep 12(2):2343–2347
Agrawal P, Singh RP, Kumari L (2017) TPGS-chitosan cross-linked targeted nanoparticles for effective brain cancer therapy. Mat Sci Engin 74:167–176
Arif U, Haider S, Haider A (2019) Biocompatible polymers and their potential biomedical applications: a review. Curr pharm Des 25(34):3608–3619
Davoodbasha M, Kim SC, Lee SY, Kim JW (2016) The facile synthesis of chitosan-based silver nano-biocomposites via a solution plasma process and their potential antimicrobial efficacy. Arch Biochem Biophy 605:49–58
Kabanov VL, Novinyuk LV (2020) Chitosan application in food technology: a review of rescent advances. Food Syst 3(1):10–15
Marques J, Valle-Delgado JJ, Urbán P (2017) Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery. Nanomedicine: Nanotechnol Biol Med 13(2):515–525
Al Shaqsi NH, Al Hoqani HA, Hossain MA, Al Sibani MA (2020) Optimization of the demineralization process for the extraction of chitin from Omani Portunidae segnis. Biochem Biophys Rep 23:100779
Xia GX, Wu YM, Bi YF (2021) Antimicrobial properties and application of polysaccharides and their derivatives. Chin J Poly Sci 39(2):133–146
Abdel-Razek N (2019) Antimicrobial activities of chitosan nanoparticles against pathogenic microorganisms in nile tilapia. Oreochromis niloticus Aquac Int 27(5):1315–1330
Prabha AR, Sivakumar K (2017) Antimicrobial activity of chitosan extracted from prawn shell. Ind J Appl Microbiol 20(1):1–7
Triunfo M, Tafi E, Guarnieri A (2021) Insect chitin-based nanomaterials for innovative cosmetics and cosmeceuticals. Cosmet 8(2):40
Rodin A, Privolnev V, Barsukov A (2018) Therapeutic potential of sulfathiazole silver for topical treatment of wound infection. Hosp Replac Technol: Ambul Surg 1–2:42–51
Divya K, Vijayan S, George TK, Jisha M (2017) Antimicrobial properties of chitosan nanoparticles: mode of action and factors affecting activity. Fibers and Poly 18(2):221–230
Rakkhumkaew N, Pengsuk C (2018) Chitosan and chitooligosaccharides from shrimp shell waste: characterization, antimicrobial and shelf life extension in bread. Food Sci Biotechnol 27(4):1201–1208
Lagat MK, Were S, Ndwigah F, Kemboi VJ, Kipkoech C, Tanga CM (2021) Antimicrobial activity of chemically and biologically treated chitosan prepared from black soldier fly (hermetia illucens) pupal shell waste. Microorg 8(9):1173
Hosseinnejad M, Jafari SM (2016) Evaluation of different factors affecting antimicrobial properties of chitosan. Int J Biol Macromol 85:467–475
Yu JY, Ko JA, Park HJ, Kim HW (2020) Application of nanochitosan in food industry: a review. Food Sci Indust 53(1):56–68
Ke CL, Deng FS, Chuang CY, Lin CH (2021) Antimicrobial actions and applications of chitosan. Polymers 13(6):904
Nhung LTT, Kim IY, Yoon YS (2020) Quaternized chitosan-based anion exchange membrane composited with quaternized poly (vinylbenzyl chloride)/polysulfone blend. Polym 12(11):2714
Ardean C, Davidescu CM, Nemeş NS, Negrea A, Ciopec M, Duteanu N, Negrea P, Duda-Seiman D, Musta V (2021) Factors influencing the antibacterial activity of chitosan and chitosan modified by functionalization. Int J Mol Sci 22(14):7449
Li J, Zhuang S (2020) Antibacterial activity of chitosan and its derivatives and their interaction mechanism with bacteria: current state and perspectives. Europ Poly J 138:109984
Butola BS (2019) Recent advances in chitosan polysaccharide and its derivatives in antimicrobial modification of textile materials. Int J Biol Macromol 121:905–912
Li XF, Feng XQ, Yang S, Fu GQ, Wang TP, Su ZX (2010) Chitosan kills escherichia coli through damage to be of cell membrane mechanism. Carbohydr Poly 79(3):493–499
Chien RC, Yen MT, Mau JL (2016) Antimicrobial and antitumor activities of chitosan from shiitake stipes, compared to commercial chitosan from crab shells. Carbohydr poly 138:259–264
Sahariah P, Cibor D, Zielińska D, Hjálmarsdóttir MÁ, Stawski D, Másson M (2019) The effect of molecular weight on the antibacterial activity of N, N, N-trimethyl chitosan (TMC). Int J Mol Sci 20(7):1743
Alarfaj AA (2019) Antibacterial effect of chitosan nanoparticles against food spoilage bacteria. J Pure Appl Microbiol 13(2):1273–1278
No HK, Prinyawiwatkul W (2009) Stability of chitosan powder during long-term storage at room temperature. J Agr Food Chem 57(18):8434–8438
Confederat LG, Tuchilus CG, Dragan M, Sha’at M, Dragostin OM, (2021) Preparation and antimicrobial activity of chitosan and its derivatives: a concise review. Mol 26(12):3694
Kamkar A, Molaee-Aghaee E, Khanjari A, Akhondzadeh-Basti A, Noudoost B, Shariatifar N, Sani MA, Soleimani M (2021) Nanocomposite active packaging based on chitosan biopolymer loaded with nano-liposomal essential oil: its characterizations and effects on microbial, and chemical properties of refrigerated chicken breast fillet. Int J Food Microbiol 342:109071
Zmejkoski DZ, Marković ZM, Budimir MD, Zdravković NM, Trišić DD, Bugárová N, Danko M, Kozyrovska NO, Špitalský Z, Kleinová A, Kuzman SB (2021) Photoactive and antioxidant nanochitosan dots/biocellulose hydrogels for wound healing treatment. Mater Sci Engin C 122:111925
Kong M, Chen XG, Xue YP (2008) Preparation and antibacterial activity of chitosan microshperes in a solid dispersing system. Front Mat Sci China 2(2):214–220
Silpa K, Reshmi V (2021) Extraction of chitosan from shrimp shell and its application as a bioactive edible coating for preservation of fish Uttar Pradesh J Zoo 10–120
Begines B, Ortiz T, Pérez-Aranda M (2020) Polymeric nanoparticles for drug delivery: recent developments and future prospects. Nanomater 10(7):1403
Alqahtani F, Aleanizy F, El Tahir E (2020) Antibacterial activity of chitosan nanoparticles against pathogenic N gonorrhoea Internat J. Nanomed 15:7877
Yanat M, Schroën K (2021) Preparation methods and applications of chitosan nanoparticles; with an outlook toward reinforcement of biodegradable packaging. React Funct Poly 8:104849
Sreekumar S, Goycoolea FM, Moerschbacher BM, Rivera-Rodriguez GR (2018) Parameters influencing the size of chitosan-TPP nano-and microparticles. Sci Rep 8(1):1–11
Mazzotta E, De Benedittis S, Qualtieri A, Muzzalupo R (2020) Actively targeted and redox responsive delivery of anticancer drug by chitosan nanoparticles. Pharm 12(1):26
Kalaivani R, Maruthupandy M, Muneeswaran T (2018) Synthesis of chitosan mediated silver nanoparticles (Ag NPs) for potential antimicrobial applications. Front Lab Med 2(1):30–35
Dara PK, Mahadevan R, Digita P (2020) Synthesis and biochemical characterization of silver nanoparticles grafted chitosan (Chi-Ag-NPs): in vitro studies on antioxidant and antibacterial applications. SN Appl Sci 2(4):1–12
Douglas-Gallardo OA, Christensen CA, Strumia MC, Pérez MA, Gomez CG (2019) Physico-chemistry of a successful micro-reactor: random coils of chitosan backbones used to synthesize size-controlled silver nanoparticles. Carbohydr Poly 225:115241
Suresh TC, Poonguzhali TV, Anuradha V, Ramesh B, Suresh G (2021) Aqueous extract of turbinaria conoides (J. Agardh) Kützing mediated fabrication of silver nanoparticles used against bacteria associated with diabetic foot ulcer. Mater Proc 43:3038–3043
Motelica L, Ficai D, Oprea OC, Ficai A, Ene VL, Vasile BS, Andronescu E, Holban AM (2021) Antibacterial biodegradable films based on alginate with silver nanoparticles and lemongrass essential oil–innovative packaging for cheese. Nanomater 11(9):2377
Xu L, Wang YY, Huang J, Chen CY, Wang ZX, Xie H (2020) Silver nanoparticles: synthesis, medical applications and biosafety. Theranostics 10(20):8996
Abbasi E, Milani M, Fekri Aval S (2016) Silver nanoparticles: synthesis methods, bio-applications and properties. Crit Rev Microbiol 42(2):173–180
Sheth Y, Dharaskar S, Khalid M, Sonawane S (2021) An environment friendly approach for heavy metal removal from industrial wastewater using chitosan based biosorbent: a review. Sustain Energy Technol Assess 43:100951
Shah A, Hussain I, Murtaza G (2018) Chemical synthesis and characterization of chitosan/silver nanocomposites films and their potential antibacterial activity. Int J Biol Macromol 116:520–529
Dimassi S, Tabary N, Chai F, Blanchemain N, Martel B (2018) Sulfonated and sulfated chitosan derivatives for biomedical applications: a review. Carbohydr poly 202:382–396
Okur ME, Karantas ID, Şenyiğit Z, Okur NÜ, Siafaka PI (2020) Recent trends on wound management: new therapeutic choices based on polymeric carriers. Asian J Pharmac Sci 15(6):661–684
González-Campos JB, Mota-Morales JD, Kumar S (2013) New insights into the bactericidal activity of chitosan-Ag bionanocomposite: the role of the electrical conductivity. Coll Surf B: Biointerfaces 111:741–746
Gaviria J, Alcudia A, Begines B (2021) Synthesis and deposition of silver nanoparticles on porous titanium substrates for biomedical applications. Surf Coat Technol 406:126667
Ahmad SA, Das SS, Khatoon A (2020) Bactericidal activity of silver nanoparticles: a mechanistic review. Mat Sci Energy Technol 6:21–28
Fatima F, Siddiqui S, Khan WA (2021) Nanoparticles as novel emerging therapeutic antibacterial agents in the antibiotics resistant era. Biol Trace Elem Res 199(7):2552–2564
Dakal TC, Kumar A, Majumdar RS, Yadav V (2016) Mechanistic basis of antimicrobial actions of silver nanoparticles. Front Microbiol 7:1831
Burdușel A-C, Gherasim O, Grumezescu AM, Mogoantă L, Ficai A, Andronescu E (2018) Biomedical applications of silver nanoparticles: an up-to-date overview. Nanomater 8(9):681
Pisárčik M, Lukáč M, Jampílek J, Bilka F, Bilková A, Pašková Ľ, Devínsky F, Horáková R, Březina M, Opravil T (2021) Silver nanoparticles stabilized with phosphorus-containing heterocyclic surfactants: synthesis physico-chemical properties and biological activity determination. Nanomater 11(8):1883
Thiruvengadam V, Bansod AV (2020) Characterization of silver nanoparticles synthesized using chemical method and its antibacterial property. Biointerface Res Appl Chem 10:7257–7264
Abdelgawad AM, El-Naggar ME, Hudson SM, Rojas OJ (2017) Fabrication and characterization of bactericidal thiol-chitosan and chitosan iodoacetamide nanofibres. Int J Biol Macromol 94:96–105
Kawish M, Ullah F, Ali HS (2020) Bactericidal potentials of silver nanoparticles: novel aspects against multidrug resistance bacteria. Elsevier, Metal Nanopart Drug Deliv Diagnostic Applicat, pp 175–188
Durán N, Durán M, Bispo M, de Jesus AB, Seabra WJ, Fávaro GN (2016) Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity. Nanomedicine: Nanotechnol Biol Med 12(3):789–799. https://doi.org/10.1016/j.nano.2015.11.016
Boateng J, Catanzano O (2020) Silver and silver nanoparticle‐based antimicrobial dressings. Therapeutic Dressings Wound Heal Appl 157-184
Yun’an Qing LC, Li R, Liu G (2018) Potential antibacterial mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification technologies. Int J Nanomed 13:3311
Hwang R, Mirshafiee V, Zhu Y, Xia T (2018) Current approaches for safer design of engineered nanomaterials. Ecotoxicol Environ Saf 166:294–300
Madkour LH (2019) Function of reactive oxygen species (ROS) inside the living organisms and sources of oxidants. Pharm Sci Anal Res JM 2:180023
Zorov DB, Juhaszova M, Sollott SJ (2014) Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 94(3):909–950
Elsholz AK, Birk MS, Charpentier E, Turgay K (2017) Functional diversity of AAA+ protease complexes in Bacillus subtilis. Front Mol Biosci 4:44
Agri U, Chaudhary P, Sharma A (2021) In vitro compatibility evaluation of agriusable nanochitosan on beneficial plant growth-promoting rhizobacteria and maize plant. Natl Acad Sci Lett 44(6):555–559. https://doi.org/10.1007/s40009-021-01047-w
Omran B, Nassar H, Younis S (2019) Physiochemical properties of trichoderma longibrachiatum DSMZ 16517-synthesized silver nanoparticles for the mitigation of halotolerant sulphate-reducing bacteria. J Appl Microbiol 126(1):138–154
Raura N, Garg A, Arora A, Roma M (2020) Nanoparticle technology and its implications in endodontics: a review. Biomat Res 24(1):1–8
Raza MA, Kanwal Z, Rauf A, Sabri AN, Riaz S, Naseem S (2016) Size-and shape-dependent antibacterial studies of silver nanoparticles synthesized by wet chemical routes. Nanomater 6(4):74
Agnihotri S, Mukherji S, Mukherji S (2014) Size-controlled silver nanoparticles synthesized over the range 5–100 nm using the same protocol and their antibacterial efficacy. Rsc Adv 4(8):3974–3983
Saleh N, Yousaf Z (2018) Tools and techniques for the optimized synthesis, reproducibility and scale up of desired nanoparticles from plant derived material and their role in pharmaceutical properties. Elsevier, Nanoscale Fabrication, Optimization, Scale-Up and Biological Aspects of Pharmaceutical Nanotechnology, pp 85–131
Liao S, Zhang Y, Pan X (2019) Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Pseudomonas aeruginosa. Int J Nanomed 14:1469
Ansari MA, Khan HM, Khan A, Cameotra S, Alzohairy M (2015) Anti-biofilm efficacy of silver nanoparticles against MRSA and MRSE isolated from wounds in a tertiary care hospital. Ind J Med Microbiol 33(1):101–109
Shaikh S, Nazam N, Rizvi SMD (2019) Mechanistic insights into the antimicrobial actions of metallic nanoparticles and their implications for multidrug resistance. Int J Mol Sci 20(10):2468
Barkat MA, Harshita F, Beg S (2018) Silver nanoparticles and their antimicrobial applications. Curr Nanomed 8(3):215–224
Mishra S, Sharma S, Javed MN (2019) Bioinspired nanocomposites: applications in disease diagnosis and treatment. Pharmaceut Nanotechnol 7(3):206–219
Singh S, Singh PK, Suhail H (2020) AMP-activated protein kinase restricts Zika virus replication in endothelial cells by potentiating innate antiviral responses and inhibiting glycolysis. J of Immunol 204(7):1810–1824
Martínez B, Rodríguez A, Kulakauskas S, Chapot-Chartier MP (2020) Cell wall homeostasis in lactic acid bacteria: threats and defences. FEMS Microbiol Rev 44(5):538–564
Rudramurthy GR, Swamy MK, Sinniah UR, Ghasemzadeh A (2016) Nanoparticles: alternatives against drug-resistant pathogenic microbes. Molecules 21(7):836
El Chakhtoura NG, Saade E, Iovleva A (2018) Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward ‘molecularly targeted’therapy. Exp Rev Anti-Infect Ther 16(2):89–110
Baptista PV, McCusker MP, Carvalho A (2018) Nano-strategies to fight multidrug resistant bacteria “A Battle of the Titans.” Front Microbiol 9:1441
Boyanova L (2018) Direct Gram staining and its various benefits in the diagnosis of bacterial infections. Postgrad Med 130(1):105–110
Das B, Sarkar C, Das D, Gupta A, Kalra A, Sahni S (2017) Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant gram-positive pathogens. Therap Advan Infect Disease 4(2):49–73
Lupo A, Haenni M, Madec JY (2018) Antimicrobial resistance in Acinetobacter spp. and Pseudomonas spp. Microbiol Spec 6(3):6301
Niño-Martínez N, Salas Orozco MF, Martínez-Castañón G-A, Torres Méndez F, Ruiz F (2019) Molecular mechanisms of bacterial resistance to metal and metal oxide nanoparticles. Int J Mol Sci 20(11):2808
Essawy E, Abdelfattah MS, El-Matbouli M, Saleh M (2021) Synergistic effect of biosynthesized silver nanoparticles and natural phenolic compounds against drug-resistant fish pathogens and their cytotoxicity: an in vitro study. Mar Drugs 19(1):22
Funding
Funding was not provided for this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethical approval
This article does not contain any studies with human participants or animals accomplished by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mumtaz, S., Ali, S., Mumtaz, S. et al. Chitosan conjugated silver nanoparticles: the versatile antibacterial agents. Polym. Bull. 80, 4719–4736 (2023). https://doi.org/10.1007/s00289-022-04321-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00289-022-04321-z